Health ❯ Medicine ❯ Pharmacology

Weight Loss

GLP-1 Medications GLP-1 Receptor Agonists GLP-1 Agonists Obesity Treatment GLP-1 Drugs Semaglutide Weight Loss Drugs Ozempic Experimental Drugs Apitegromab Hormonal Treatments Appetite Suppression Genetic Influence Wegovy GLP-1 Analogues Salcaprozate Sodium RNA Medicines Mounjaro Weight Loss Injections Brown Adipose Tissue Anti-Obesity Medications Muscle Mass Obesity Medications Retatrutide Tridecaneuropeptide (TDN) Weight-Loss Injections Tirzepatide

GLP‑1 Drugs Move into the Mainstream as UK Clears Oral Wegovy and Tirzepatide Shows Bigger Weight Loss

Regulatory approval of an oral semaglutide pill plus new comparative data could accelerate use and expose gaps in response, safety and access in obesity care.

Tirzepatide Raises Imaging Signals of Brown Adipose Tissue in Small Randomized Trial

Experimental Antibody Preserves Muscle During Tirzepatide Weight Loss

Resalis’ miR-22 Antisense Shows Durable Fat Loss in Animals as Phase 1 Trial Continues

Tufts Team Designs Experimental Four-Hormone Obesity Drug Aimed at Bigger, Gentler Weight Loss

Astrocyte-Derived Peptide Achieves Nausea-Free Weight Loss in Animal Models

Novo Nordisk’s Amycretin Achieves Up to 24% Weight Loss as It Advances to Phase 3

Real-World GLP-1 Therapy Yields Lower Weight Loss, Spurs Tetra-Receptor Drug Research